Published January 15, 2024 | Version v1
Publication Restricted

Dataset related to the article "Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis"

  • 1. Centro Cardiologico Monzino IRCCS
  • 2. Dipartimento di Biologia e Biotecnologie "Lazzaro Spallanzani", Università di Pavia; Centro Cardiologico Monzino IRCCS
  • 3. Science for Life Laboratory, KTH—Royal Institute of Technology, Tomtebodavägen, Solna

Description

This record contains raw data related to the article “Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis"

Abstract: The process of adipogenesis involves the differentiation of preadipocytes into mature
adipocytes. Excessive adipogenesis promotes obesity, a condition that increasingly threatens global
health and contributes to the rapid rise of obesity-related diseases. We have recently shown that
prenylcysteine oxidase 1 (PCYOX1) is a regulator of atherosclerosis-disease mechanisms, which
acts through mechanisms not exclusively related to its pro-oxidant activity. To address the role
of PCYOX1 in the adipogenic process, we extended our previous observations confirming that
Pcyox1􀀀/􀀀/Apoe􀀀/􀀀 mice fed a high-fat diet for 8 or 12 weeks showed significantly lower body
weight, when compared to Pcyox1+/+/Apoe􀀀/􀀀 mice, due to an evident reduction in visceral adipose
content. We herein assessed the role of PCYOX1 in adipogenesis. Here, we found that PCYOX1 is
expressed in adipose tissue, and, independently from its pro-oxidant enzymatic activity, is critical for
adipogenesis. Pcyox1 gene silencing completely prevented the differentiation of 3T3-L1 preadipocytes,
by acting as an upstream regulator of several key players, such as FABP4, PPAR , C/EBP. Proteomic
analysis, performed by quantitative label-free mass spectrometry, further strengthened the role of
PCYOX1 in adipogenesis by expanding the list of its downstream targets. Finally, the absence of
Pcyox1 reduces the inflammatory markers in adipose tissue. These findings render PCYOX1 a novel
adipogenic factor with possible pathophysiological or therapeutic potential.

Notes

This work was supported by the Italian Ministry of Health, Italy, Ricerca Corrente 2021, Centro Cardiologico Monzino IRCCS

Files

Restricted

The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/7774634">Log in</a> to check if you have access.

Request access

If you would like to request access to these files, please fill out the form below.

You need to satisfy these conditions in order for this request to be accepted:

your request to direzione.scientifica@ccfm.it

You are currently not logged in. Do you have an account? Log in here

Additional details

Related works

Is supplement to
Journal article: 10.3390/antiox12030542 (DOI)

Funding

Ministry of Health
Ricerca Corrente to Centro Cardiologico Monzino IRCCS RC